Nownews財經新聞: 台灣神隆、Foresee合作 開發抗癌胜肽針劑新藥

Nownews財經新聞 www.nownews.com

台灣神隆、Foresee合作　開發抗癌胜肽針劑新藥 Jan 30th 2013, 10:06 〔記者楊伶雯╱台北報導〕台灣神隆與Foresee製藥公司(Foresee Pharmaceuticals, Inc.)30日宣布簽署投資合作協議，雙方將共同出資成立合資公司從事抗癌胜肽,針劑新藥研發，未來透過新穎之控釋給藥系統(controlled-release drug delivery system) 專利平台技術，開發高技術門檻、高單價、高利潤之抗癌胜肽,新藥。

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions